Investor Relations

(Security Code :4506 TSE Prime)

Pick Up

Nov. 07, 2025	Posted Conference on Q2 FY2025 Financial Results [Webcast]	Finances
Nov. 04, 2025	Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting（PDF/81KB）	R&D
Oct. 31, 2025	Presentation Material (Conference on Q2 FY2025 Financial Results)（PDF/688KB）	Finances
Oct. 31, 2025	Supplementary Financial Data (IFRS) for the Second Quarter of the Year Ending March 31, 2026（PDF/270KB）	Finances
Oct. 31, 2025	Summary of Consolidated Financial Results for the Second Quarter (First Half) of the Year Ending March 31, 2026 [IFRS]（PDF/464KB）	Finances
Oct. 31, 2025	Sumitomo Pharma Announces Variances Between Its Financial Forecasts and the Actual Results for the Half-Year Ended September 30, 2025, and Revisions to Its Financial Forecasts for the Year Ending March 31, 2026	Finances

Jan. 30, 2026	3nd Quarter of FY2025 financial results announcement (planned, 3:30 p.m.)